Temozolamide (100mg)

TMOZOLMIDE 100 contains Temozolomide 100 mg, an oral chemotherapy medication widely used for the treatment of certain brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. Temozolomide belongs to the class of alkylating agents, which work by interfering with the DNA of cancer cells, preventing their replication and growth.

This medication is particularly effective in targeting rapidly dividing cancer cells while minimizing damage to normal cells. TMOZOLMIDE 100 is designed for oral administration, offering convenience for patients undergoing long-term treatment under strict medical supervision.

Temozolomide has become a cornerstone in oncology therapy for high-grade brain tumors, often used in combination with radiation therapy or as a maintenance treatment following surgery.

Uses of TMOZOLMIDE 100

1. Treatment of Glioblastoma Multiforme:
   Used in combination with radiotherapy or as maintenance therapy to slow tumor growth and improve survival rates.

2. Anaplastic Astrocytoma:
   Prescribed for patients with this type of malignant brain tumor, either post-surgery or after relapse.

3. Cancer Management Post-Surgery:
   Helps destroy remaining cancer cells after surgical removal of brain tumors.

4. Combination Therapy:
   Often administered alongside radiation therapy or other chemotherapeutic agents for enhanced efficacy.

5. Improving Progression-Free Survival:
   Regular use has been shown to delay tumor progression and improve quality of life in patients with aggressive brain tumors.

Key Benefits of TMOZOLMIDE 100

• Targeted Action Against Cancer Cells:
  Temozolomide specifically interferes with the DNA of tumor cells, reducing proliferation and tumor size over time.

• Convenient Oral Formulation:
  Capsules can be taken at home under medical supervision, reducing the need for frequent hospital visits compared to intravenous chemotherapy.

• Enhanced Treatment Outcomes:
  When combined with radiation therapy, TMOZOLMIDE 100 has been shown to increase overall survival rates in glioblastoma patients.

• Maintenance Therapy Option:
  Can be used as part of a long-term treatment plan to maintain tumor control after initial therapy.

• Supports Multimodal Treatment Plans:
  Works effectively alongside surgery, radiotherapy, or other chemotherapy agents for comprehensive cancer management.

Dosage and Administration

• TMOZOLMIDE 100 is prescribed by an oncologist based on the type, size, and progression of the tumor.

• Capsules are typically taken once daily, preferably on an empty stomach or as advised by the physician.

• The dosage may vary according to body surface area and treatment cycle, which often includes days on medication followed by rest periods to allow the body to recover.

• Swallow the capsules whole; do not crush or chew.

Possible Side Effects of TMOZOLMIDE 100

Like all chemotherapy medications, TMOZOLMIDE 100 can cause side effects. Most are temporary and manageable under medical supervision.

Common Side Effects:

• Nausea and vomiting

• Loss of appetite

• Fatigue or weakness

• Hair thinning or hair loss

• Constipation or diarrhea

Less Common but Serious Side Effects:

• Low blood cell counts (anemia, leukopenia, thrombocytopenia)

• Increased risk of infections

• Liver function abnormalities

• Severe allergic reactions (rare)

Patients are advised to have regular blood tests to monitor blood counts and liver function during treatment. Prompt reporting of severe side effects to the oncologist is essential.

Precautions and Safety Advice

• Avoid using TMOZOLMIDE 100 during pregnancy or breastfeeding.

• Patients with liver or kidney problems should be closely monitored.

• Maintain adequate hydration and follow dietary recommendations to minimize nausea and digestive issues.

• Do not take over-the-counter medications or herbal supplements without consulting your doctor, as they may interfere with treatment.

• Practice infection control measures, as chemotherapy may reduce immunity.

Conclusion

TMOZOLMIDE 100 by Steris Healthcare Pvt. Ltd. is a highly effective oral chemotherapy option for patients with aggressive brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. By targeting cancer cell DNA, it helps slow tumor growth, prolong survival, and enhance treatment outcomes when used alongside surgery and radiation therapy.

With careful medical supervision, regular monitoring, and adherence to prescribed cycles, TMOZOLMIDE 100 provides a reliable and convenient approach to managing brain tumors, empowering patients and healthcare providers in the fight against cancer.

Choose TMOZOLMIDE 100 a clinically proven ally in your cancer treatment journey.